Letter to the Editor
Renal denervation for hypertension: we’ve come a long way!
Abstract
Renal sympathetic denervation (RSD), a therapeutic intervention for patients with hypertension (HTN), is undergoing active investigation. Prospective cohort studies and first-generation randomized controlled studies established the safety of RSD but its impact on blood pressure was variable (1-3).
